XML 41 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders’ Equity (Tables)
9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Schedule of Changes in Stockholders’ Equity

The following tables present changes in stockholders’ equity for the nine-month periods ended September 30, 2023 and 2022 (in thousands, except share data):

 

 

 

 

 

 

 

Additional

 

 

Accumulated Other

 

 

 

 

 

Total

 

 

Common

 

 

Paid-In

 

 

Comprehensive

 

 

Accumulated

 

 

Stockholders’

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Loss

 

 

Deficit

 

 

Equity

 

Balance at December 31, 2022

 

87,103,007

 

 

$

9

 

 

$

2,420,223

 

 

$

(7,461

)

 

$

(1,177,187

)

 

$

1,235,584

 

Issuance of common stock through
   at-the-market offerings, net of
   issuance costs of $
62

 

35,349

 

 

 

-

 

 

 

1,466

 

 

 

-

 

 

 

-

 

 

 

1,466

 

Contingent consideration paid to Rewrite Holders

 

567,045

 

 

 

-

 

 

 

24,126

 

 

 

-

 

 

 

-

 

 

 

24,126

 

Exercise of stock options

 

48,353

 

 

 

-

 

 

 

755

 

 

 

-

 

 

 

-

 

 

 

755

 

Vesting of restricted stock units

 

342,025

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Equity-based compensation

 

-

 

 

 

-

 

 

 

27,255

 

 

 

-

 

 

 

-

 

 

 

27,255

 

Other comprehensive loss - unrealized gain on
   marketable securities

 

-

 

 

 

-

 

 

 

-

 

 

 

2,989

 

 

 

-

 

 

 

2,989

 

Other comprehensive loss - equity method
   investment

 

-

 

 

 

-

 

 

 

-

 

 

 

1,794

 

 

 

-

 

 

 

1,794

 

Net loss

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

(103,126

)

 

 

(103,126

)

Balance at March 31, 2023

 

88,095,779

 

 

 

9

 

 

2,473,825

 

 

(2,678

)

 

 

(1,280,313

)

 

 

1,190,843

 

Exercise of stock options

 

30,371

 

 

 

-

 

 

 

465

 

 

 

-

 

 

 

-

 

 

 

465

 

Vesting of restricted stock units

 

151,853

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Issuance of shares under employee
   stock purchase plan

 

69,631

 

 

 

-

 

 

 

2,051

 

 

 

-

 

 

 

-

 

 

 

2,051

 

Equity-based compensation

 

-

 

 

 

-

 

 

 

36,400

 

 

 

-

 

 

 

-

 

 

 

36,400

 

Other comprehensive loss - unrealized loss on
   marketable securities

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,482

)

 

 

-

 

 

 

(1,482

)

Other comprehensive loss - equity method
   investment

 

-

 

 

 

-

 

 

 

-

 

 

 

292

 

 

 

-

 

 

 

292

 

Net loss

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(123,681

)

 

 

(123,681

)

Balance at June 30, 2023

 

88,347,634

 

 

 

9

 

 

 

2,512,741

 

 

 

(3,868

)

 

 

(1,403,994

)

 

 

1,104,888

 

Issuance of common stock through
   at-the-market offerings, net of
   issuance costs of $
81

 

405,332

 

 

 

-

 

 

 

14,718

 

 

 

-

 

 

 

-

 

 

 

14,718

 

Exercise of stock options

 

241,123

 

 

 

-

 

 

 

4,384

 

 

 

-

 

 

 

-

 

 

 

4,384

 

Vesting of restricted stock units

 

103,732

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Equity-based compensation

 

-

 

 

 

-

 

 

 

35,352

 

 

 

-

 

 

 

-

 

 

 

35,352

 

Other comprehensive loss - unrealized gain on marketable securities

 

-

 

 

 

-

 

 

 

-

 

 

 

142

 

 

 

-

 

 

 

142

 

Other comprehensive loss - equity method investment

 

-

 

 

 

-

 

 

 

-

 

 

 

154

 

 

 

-

 

 

 

154

 

Net loss

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(122,224

)

 

 

(122,224

)

Balance at September 30, 2023

 

89,097,821

 

 

$

9

 

 

$

2,567,195

 

 

$

(3,572

)

 

$

(1,526,218

)

 

$

1,037,414

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Accumulated Other

 

 

 

 

 

Total

 

 

Common

 

 

Paid-In

 

 

Comprehensive

 

 

Accumulated

 

 

Stockholders’

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Loss

 

 

Deficit

 

 

Equity

 

Balance at December 31, 2021

 

74,485,883

 

 

$

7

 

 

$

1,745,870

 

 

$

(2,632

)

 

$

(703,001

)

 

$

1,040,244

 

Issuance of common stock through
   at-the-market offerings, net of
   issuance costs of $
164

 

579,788

 

 

 

1

 

 

 

38,885

 

 

 

-

 

 

 

-

 

 

 

38,886

 

Exercise of stock options

 

503,830

 

 

 

-

 

 

 

8,435

 

 

 

-

 

 

 

-

 

 

 

8,435

 

Vesting of restricted stock units

 

54,666

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Equity-based compensation

 

-

 

 

 

-

 

 

 

18,491

 

 

 

-

 

 

 

-

 

 

 

18,491

 

Other comprehensive loss - unrealized loss on
   marketable securities

 

-

 

 

 

-

 

 

 

-

 

 

 

(5,128

)

 

 

-

 

 

 

(5,128

)

Other comprehensive loss - equity method
   investment

 

-

 

 

 

-

 

 

 

-

 

 

 

(302

)

 

 

-

 

 

 

(302

)

Net loss

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(146,872

)

 

 

(146,872

)

Balance at March 31, 2022

 

75,624,167

 

 

 

8

 

 

1,811,681

 

 

(8,062

)

 

 

(849,873

)

 

 

953,754

 

Exercise of stock options

 

315,747

 

 

 

-

 

 

 

4,827

 

 

 

-

 

 

 

-

 

 

 

4,827

 

Vesting of restricted stock units

 

36,515

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Issuance of shares under employee
   stock purchase plan

 

24,316

 

 

 

-

 

 

 

1,068

 

 

 

-

 

 

 

-

 

 

 

1,068

 

Equity-based compensation

 

-

 

 

 

-

 

 

 

23,068

 

 

 

-

 

 

 

-

 

 

 

23,068

 

Other comprehensive loss - unrealized loss on
   marketable securities

 

-

 

 

 

-

 

 

 

-

 

 

 

(932

)

 

 

-

 

 

 

(932

)

Other comprehensive loss - equity method
   investment

 

-

 

 

 

-

 

 

 

-

 

 

 

(560

)

 

 

-

 

 

 

(560

)

Net loss

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(100,678

)

 

 

(100,678

)

Balance at June 30, 2022

 

76,000,745

 

 

 

8

 

 

1,840,644

 

 

(9,554

)

 

 

(950,551

)

 

 

880,547

 

Issuance of common stock through
   at-the-market offerings, net of
   issuance costs of $
54

 

553,204

 

 

 

-

 

 

 

31,510

 

 

 

-

 

 

 

-

 

 

 

31,510

 

Exercise of stock options

 

33,336

 

 

 

-

 

 

 

722

 

 

 

-

 

 

 

-

 

 

 

722

 

Vesting of restricted stock units

 

662

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Equity-based compensation

 

-

 

 

 

-

 

 

 

25,215

 

 

 

-

 

 

 

-

 

 

 

25,215

 

Other comprehensive loss - unrealized gain on marketable securities

 

-

 

 

 

-

 

 

 

-

 

 

 

991

 

 

 

-

 

 

 

991

 

Other comprehensive loss - equity method investment

 

-

 

 

 

-

 

 

 

-

 

 

 

(805

)

 

 

-

 

 

 

(805

)

Net loss

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(113,229

)

 

 

(113,229

)

Balance at September 30, 2022

 

76,587,947

 

 

$

8

 

$

1,898,091

 

$

(9,368

)

 

$

(1,063,780

)

 

$

824,951